CancerNCT06081452
Public Survey on Breath Testing for Health and Disease
An observational study of Cancer and Disease, run by Imperial College London at 1 site in United Kingdom.
Trial summary
A brief survey for the public to determine interest in health surveillance and disease detection Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cancer, Disease, Health Behavior
- What is being tested?
- Survey
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 1,000 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 17 Jun 2023to 17 Oct 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Our aim is to acquire a wide breadth of information from all members of the public, irrespective of the demographics, socioeconomic status and ethnicity. All member of the public, above the age of 18 are welcome to participate
Who may be able to join
- Member of the public above the age of 18
Who cannot join
- Member of the public below the age of 18
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Munir Tarazi contact
United Kingdom1 site, 1 recruiting
- Recruiting
Imperial College London
London
Pallavi Huma Arya, h.arya@imperial.ac.uk
About this study
A brief survey for the public to determine interest in health surveillance and disease detection
Read the detailed description
There are numerous barriers and favourable conditions that affect the acceptability of a screening test for cancer. Such factors have been investigated in the context of some of the current screening programs. Through this survey the investigators want to increase researcher awareness of these factors with the hope that this information will aid policy makers and guide future research.
There has been widening public interest in general health-surveillance in addition to disease detection. Breath testing has the potential to be a one-for-all non-invasive test to detect health domains. Through this survey, the investigators wish to understand public opinions about breath testing for health.
This survey consists of questions aiming to gather views on non-invasive testing for health and disease.
- Conditions
- Cancer, Disease, Health Behavior, Health Attitude, Health-Related Behavior, Health Knowledge, Attitudes, Practice
- Being tested
- Survey
- Medical subject headings
- Neoplasms, Disease, Health Behavior, Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SurveyBehavioural
Members of the public will be asked to complete a survey that collects information on individuals perception of health and disease and their views on breath testing.
| Study group | Role | What they receive |
|---|---|---|
| Public | General public to be approached to answer this survey via GPs, charities and exhibitions such as Great Exhibition Road Festival. Receives: Behavioral: Survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
Acceptability of breath testing
Proportion of people that find breath testing an acceptable means to determine health or disease
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Oct 2023
- Study start17 Jun 2023
- Primary completion17 Jun 2025 (estimated)
- Study completion17 Oct 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- More trials run by Imperial College LondonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Prospective
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Imperial College London
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- George Hanna, PhD, Study director, Imperial College London
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06081452
- Sponsor's protocol ID
- 6634264
- Status last verified
- Jan 2025
- First submitted
- 6 Oct 2023
- Last updated
- 28 Jan 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 28 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Public Survey on Breath Testing for Health and Disease
- ClinicalTrials.gov ID
- NCT06081452
- Acronym / sponsor ID
- 6634264
- Conditions
- Cancer, Disease, Health Behavior, Health Attitude, Health-Related Behavior, Health Knowledge, Attitudes, Practice
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- Imperial College LondonUniversity, hospital or other
- Study start
- 17 Jun 2023 (actual)
- Primary completion
- 17 Jun 2025 (estimated)
- Study completion
- 17 Oct 2025 (estimated)
- First posted
- 13 Oct 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A brief survey for the public to determine interest in health surveillance and disease detection
Detailed description
There are numerous barriers and favourable conditions that affect the acceptability of a screening test for cancer. Such factors have been investigated in the context of some of the current screening programs. Through this survey the investigators want to increase researcher awareness of these factors with the hope that this information will aid policy makers and guide future research.
There has been widening public interest in general health-surveillance in addition to disease detection. Breath testing has the potential to be a one-for-all non-invasive test to detect health domains. Through this survey, the investigators wish to understand public opinions about breath testing for health.
This survey consists of questions aiming to gather views on non-invasive testing for health and disease.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Public | – | Behavioral: SurveyGeneral public to be approached to answer this survey via GPs, charities and exhibitions such as Great Exhibition Road Festival. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Our aim is to acquire a wide breadth of information from all members of the public, irrespective of the demographics, socioeconomic status and ethnicity. All member of the public, above the age of 18 are welcome to participate
Key inclusion criteria (1 listed)
- Member of the public above the age of 18
Key exclusion criteria (1 listed)
- Member of the public below the age of 18
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SurveyMembers of the public will be asked to complete a survey that collects information on individuals perception of health and disease and their views on breath testing. | Behavioural | Public |
Primary outcome
Acceptability of breath testing
Time frame: 6 months
Proportion of people that find breath testing an acceptable means to determine health or disease
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jan 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Munir Tarazi contact
George Hanna, PhD study director
Imperial College London
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer and Disease, run by Imperial College London at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 28 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Pallavi Huma Arya (02075948197, h.arya@imperial.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Acceptability of breath testing (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2025.